Indian drugmaker Wockhardt Ltd <WCKH.NS> will provide thousands and thousands of doses of a number of COVID-19 vaccines to the UK, together with the one being developed by AstraZeneca <AZN.L> and Oxford University, it mentioned on Monday.
The firm has reserved fill-and-finish capability – the ultimate manufacturing step of placing vaccines into vials or syringes and packaging them – as a part of an settlement with the UK authorities, it mentioned.
Shares in Wockhardt jumped 10% after the information in a downcast Mumbai market. [.BO]
The UK authorities has additionally reserved one fill-and-finish manufacturing line at a Wockhardt subsidiary in Wrexham, Wales for its unique use for the following 18 months to safe provide.
More than 150 vaccines are being developed and examined all over the world to cease the pandemic, with 25 in human scientific trials, in response to the World Health Organization.
Coronavirus circumstances globally have crossed 18 million, together with greater than 688,000 deaths.
(This story has not been edited by NDTV workers and is auto-generated from a syndicated feed.)